9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine has been researched along with Cytomegalic Inclusion Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Clercq, E; Neyts, J | 1 |
Balzarini, J; De Clercq, E; Holy, A; Naesens, L; Neyts, J; Rosenberg, I | 1 |
Bruggeman, C; De Clercq, E; Neyts, J; Stals, F | 1 |
Andrei, G; De Clercq, E; Snoeck, R | 1 |
4 other study(ies) available for 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine and Cytomegalic Inclusion Disease
Article | Year |
---|---|
New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
Topics: Adenine; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Ganciclovir; Herpesviridae Infections; Humans; Immunologic Deficiency Syndromes; Mice; Mice, SCID; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Virus Replication | 1994 |
Efficacy of oral 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the treatment of retrovirus and cytomegalovirus infections in mice.
Topics: Adenine; Administration, Oral; Animals; Antiviral Agents; Cytomegalovirus Infections; Friend murine leukemia virus; Injections, Intraperitoneal; Leukemia, Experimental; Mice; Moloney murine sarcoma virus; Sarcoma, Experimental; Survival Rate; Treatment Outcome | 1993 |
Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo.
Topics: Adenine; Animals; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; DNA Replication; DNA, Viral; Fibroblasts; Humans; Immunocompromised Host; Mice; Mice, SCID; Rats | 1993 |
Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
Topics: Acyclovir; Adenine; Antiviral Agents; Cells, Cultured; Cidofovir; Cytarabine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Fibroblasts; Foscarnet; Humans; Lung; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid | 1996 |